Evolus Inc (EOLS): Next-Year EPS Estimate 384.35%
As of 2026-06-11, Evolus Inc (EOLS) has a next-year EPS growth estimate of 384.35%.
On 2026-06-09, analyst consensus for EOLS's next-year EPS growth shifted from 383.69% to 384.35% — a positive change of 0.66 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 78.64%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 384.35%
- EPS growth this year
- 78.64%
- EPS next quarter (est)
- -$0.04
- Last price
- $6.51
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 384.35% | 78.64% | -$0.04 | $6.51 |
| 2026-06-10 | 384.35% | 78.64% | -$0.04 | $6.72 |
| 2026-06-09 | 384.35% | 78.64% | -$0.04 | $6.70 |
| 2026-06-08 | 383.69% | 78.59% | -$0.04 | $6.68 |
| 2026-06-07 | 383.69% | 78.59% | -$0.04 | $6.67 |
| 2026-06-04 | 383.69% | 78.59% | -$0.04 | $6.60 |
| 2026-06-03 | 383.69% | 78.59% | -$0.04 | $6.03 |
| 2026-06-02 | 383.69% | 78.59% | -$0.04 | $6.17 |
| 2026-06-01 | 383.69% | 78.59% | -$0.04 | $6.52 |
| 2026-05-31 | 383.69% | 78.59% | -$0.04 | $6.56 |
| 2026-05-28 | 383.69% | 78.59% | -$0.04 | $6.57 |
| 2026-05-27 | 383.69% | 78.59% | -$0.04 | $6.18 |
| 2026-05-26 | 383.69% | 78.59% | -$0.04 | $6.25 |
| 2026-05-25 | 383.69% | 78.59% | -$0.04 | $6.09 |
| 2026-05-24 | 383.69% | 78.59% | -$0.04 | $6.09 |
| 2026-05-21 | 383.69% | 78.59% | -$0.04 | $6.45 |
| 2026-05-20 | 383.69% | 78.59% | -$0.04 | $6.59 |
| 2026-05-19 | 383.69% | 78.59% | -$0.04 | $6.43 |
| 2026-05-18 | 383.69% | 78.59% | -$0.04 | $6.57 |
| 2026-05-17 | 383.69% | 78.59% | -$0.04 | $6.50 |
| 2026-05-14 | 383.69% | 78.59% | -$0.04 | $6.58 |
| 2026-05-13 | 383.69% | 78.59% | -$0.04 | $6.66 |
| 2026-05-12 | 383.69% | 78.59% | -$0.04 | $6.50 |
| 2026-05-11 | 383.69% | 78.59% | -$0.04 | $6.32 |
| 2026-05-10 | 383.69% | 78.59% | -$0.04 | $6.36 |
| 2026-05-07 | 383.69% | 78.59% | -$0.04 | $6.39 |
| 2026-05-06 | 383.69% | 78.59% | -$0.04 | $6.32 |
| 2026-05-05 | 383.69% | 78.59% | -$0.04 | $6.37 |
| 2026-05-04 | 411.92% | 80.29% | -$0.11 | $5.58 |
| 2026-05-03 | 411.92% | 80.29% | -$0.11 | $5.33 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Evolus Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Evolus Inc (EOLS) has a next-year EPS growth estimate of 384.35%, based on analyst consensus.
When was the latest EPS estimate revision for EOLS?▾
The most recent revision occurred on 2026-06-09, when analysts adjusted the next-year EPS growth estimate from 383.69% to 384.35%.
What sector and industry does Evolus Inc belong to?▾
Evolus Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EOLS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Evolus Inc (EOLS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports